{"id":"nct:NCT05030428","kind":"trial","title":"Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease","authors":["Novartis Pharmaceuticals"],"author_count":1,"year":2021,"published":"2021-09-01","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT05030428","source_url":"https://clinicaltrials.gov/study/NCT05030428","archive_url":"https://space-kitty.com/papers/nct:NCT05030428","updated":"2026-08-25","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Atherosclerotic Cardiovascular Disease"],"details":{"acronym":"VICTORION-2P","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":17004,"sponsor":"Novartis Pharmaceuticals","conditions":["Atherosclerotic Cardiovascular Disease"],"interventions":["DRUG: Inclisiran sodium 300 mg","DRUG: Placebo"],"start_date":"2021-11-23","start_date_type":"ACTUAL","primary_completion_date":"2027-05-10","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}